Novo Nordisk Partners With Anthropic to Speed Drug Development With AI
Novo Nordisk partners with Anthropic to accelerate drug development with AI as CEO Mike Doustdar pushes to make the company the world’s most AI-driven healthcare business amid fierce obesity-market competition.